| Charles Matthew Gibellato, MD | |
|
8200 Meadowbridge Rd, Suite 200, Mechanicsville, VA 23116-2331 | |
| (804) 730-2121 | |
| Not Available |
| Full Name | Charles Matthew Gibellato |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 21 Years |
| Location | 8200 Meadowbridge Rd, Mechanicsville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528013836 | NPI | - | NPPES |
| 010133360 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 0101237142 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Memorial Regional Medical Center | Mechanicsville, VA | Hospital |
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthovirginia Inc | 0547157224 | 492 |
News Archive
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
Researchers supported by the Swiss National Science Foundation have discovered how aggressive cells can invade healthy tissue during the earliest stage of tumour development. This opens up new ways of attacking cancer at its root.
The UK Prime Minister Rt Hon Theresa May today joined key stakeholders from across the life sciences sector to open the Wellcome Trust Sanger Institute's new Bridget Ogilvie Building and the Biodata Innovation Centre at the Wellcome Genome Campus in Cambridge.
A study in the Annals of Internal Medicine shows that walking three times a week, even in an unsupervised exercise program, can significantly improve walking ability and slow progression of peripheral artery disease (PAD). PAD often causes leg pain because of impaired blood flow in the arteries.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of ExploraSep 96-well screening plates to identify optimum scavengers. The 4 different screening plates deliver 128 selective resins based on high-performance, Molecularly Imprinted Polymers (MIPs). Biotage provides professional MIPs technical consultation, information on additional formats as well as assistance with data interpretation and process development.
› Verified 6 days ago
| Entity Name | Orthovirginia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487671822 PECOS PAC ID: 0547157224 Enrollment ID: O20040228000320 |
News Archive
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
Researchers supported by the Swiss National Science Foundation have discovered how aggressive cells can invade healthy tissue during the earliest stage of tumour development. This opens up new ways of attacking cancer at its root.
The UK Prime Minister Rt Hon Theresa May today joined key stakeholders from across the life sciences sector to open the Wellcome Trust Sanger Institute's new Bridget Ogilvie Building and the Biodata Innovation Centre at the Wellcome Genome Campus in Cambridge.
A study in the Annals of Internal Medicine shows that walking three times a week, even in an unsupervised exercise program, can significantly improve walking ability and slow progression of peripheral artery disease (PAD). PAD often causes leg pain because of impaired blood flow in the arteries.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of ExploraSep 96-well screening plates to identify optimum scavengers. The 4 different screening plates deliver 128 selective resins based on high-performance, Molecularly Imprinted Polymers (MIPs). Biotage provides professional MIPs technical consultation, information on additional formats as well as assistance with data interpretation and process development.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Matthew Gibellato, MD 1115 Boulders Pkwy 200, North Chesterfield, VA 23225-4067 Ph: (804) 560-5595 | Charles Matthew Gibellato, MD 8200 Meadowbridge Rd, Suite 200, Mechanicsville, VA 23116-2331 Ph: (804) 730-2121 |
News Archive
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
Researchers supported by the Swiss National Science Foundation have discovered how aggressive cells can invade healthy tissue during the earliest stage of tumour development. This opens up new ways of attacking cancer at its root.
The UK Prime Minister Rt Hon Theresa May today joined key stakeholders from across the life sciences sector to open the Wellcome Trust Sanger Institute's new Bridget Ogilvie Building and the Biodata Innovation Centre at the Wellcome Genome Campus in Cambridge.
A study in the Annals of Internal Medicine shows that walking three times a week, even in an unsupervised exercise program, can significantly improve walking ability and slow progression of peripheral artery disease (PAD). PAD often causes leg pain because of impaired blood flow in the arteries.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of ExploraSep 96-well screening plates to identify optimum scavengers. The 4 different screening plates deliver 128 selective resins based on high-performance, Molecularly Imprinted Polymers (MIPs). Biotage provides professional MIPs technical consultation, information on additional formats as well as assistance with data interpretation and process development.
› Verified 6 days ago
Shawnna Ann English, SPEECH PATHOLOGIST Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8254 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-342-4300 Fax: 804-342-4316 | |
Beverly Dupre, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8254 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-342-4300 Fax: 804-342-4316 | |
Mrs. Annette Alyson Keffer, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7600 Autumn Park Way, Mechanicsville, VA 23116 Phone: 804-730-0009 | |
Gregory F. Leghart, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8254 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-342-4335 Fax: 804-342-4316 | |
Kristen Ayn Barrett, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8254 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-342-4300 Fax: 804-342-4316 | |
Timothy M. Silver, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8254 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-342-4335 Fax: 804-342-4316 |